Effect of OR51E1 single nucleotide polymorphisms on glioma susceptibility in the Chinese Han population.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
30 Jul 2023
Historique:
received: 23 03 2023
revised: 27 04 2023
accepted: 12 05 2023
medline: 14 6 2023
pubmed: 20 5 2023
entrez: 19 5 2023
Statut: ppublish

Résumé

Glioma is one of the common primary intracranial tumors, which is heterogeneous among individuals with a low cure rate. Our study aimed to investigate the association between single nucleotide polymorphisms (SNPs) of the OR51E1 gene and glioma susceptibility in the Chinese Han population. A total of six SNPs on OR51E1 in 1,026 subjects (526 cases and 500 controls) were genotyped by MassARRAY iPLEX GOLD assay. The association between these SNPs and glioma susceptibility was analyzed using logistic regression, and odds ratios (ORs) and 95% confidence intervals (CIs) were also calculated. The multifactor dimensionality reduction (MDR) method was applied to detect "SNP-SNP" interactions. In the overall sample, polymorphisms rs10768148, rs7102992, and rs10500608 were identified to be associated with glioma risk. In the stratified analysis based on gender, only polymorphism rs10768148 was observed to be associated with the risk of glioma. In the age-stratified analysis, rs7102992, rs74052483, and rs10500609 contributed to the risk of glioma in subjects aged > 40 years. And polymorphisms rs10768148 and rs7102992 were associated with the risk of glioma in subjects aged ≤ 40 years and subjects with astrocytoma. In addition, a strong synergistic relationship between rs74052483 and rs10768148, and a strong redundant relationship between rs7102992 and rs10768148 were identified in the study. This study demonstrated the association of OR51E1 polymorphisms with glioma susceptibility, providing a basis for assessing glioma risk-associated variants in the Chinese Han population.

Sections du résumé

BACKGROUND BACKGROUND
Glioma is one of the common primary intracranial tumors, which is heterogeneous among individuals with a low cure rate. Our study aimed to investigate the association between single nucleotide polymorphisms (SNPs) of the OR51E1 gene and glioma susceptibility in the Chinese Han population.
METHODS METHODS
A total of six SNPs on OR51E1 in 1,026 subjects (526 cases and 500 controls) were genotyped by MassARRAY iPLEX GOLD assay. The association between these SNPs and glioma susceptibility was analyzed using logistic regression, and odds ratios (ORs) and 95% confidence intervals (CIs) were also calculated. The multifactor dimensionality reduction (MDR) method was applied to detect "SNP-SNP" interactions.
RESULTS RESULTS
In the overall sample, polymorphisms rs10768148, rs7102992, and rs10500608 were identified to be associated with glioma risk. In the stratified analysis based on gender, only polymorphism rs10768148 was observed to be associated with the risk of glioma. In the age-stratified analysis, rs7102992, rs74052483, and rs10500609 contributed to the risk of glioma in subjects aged > 40 years. And polymorphisms rs10768148 and rs7102992 were associated with the risk of glioma in subjects aged ≤ 40 years and subjects with astrocytoma. In addition, a strong synergistic relationship between rs74052483 and rs10768148, and a strong redundant relationship between rs7102992 and rs10768148 were identified in the study.
CONCLUSIONS CONCLUSIONS
This study demonstrated the association of OR51E1 polymorphisms with glioma susceptibility, providing a basis for assessing glioma risk-associated variants in the Chinese Han population.

Identifiants

pubmed: 37207826
pii: S0378-1119(23)00330-X
doi: 10.1016/j.gene.2023.147489
pii:
doi:

Substances chimiques

OR51E1 protein, human 0
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

147489

Informations de copyright

Copyright © 2023 Elsevier B.V. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Auteurs

Jie Wei (J)

College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Huan Zhang (H)

College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Xiaoya Ma (X)

College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Yujie Li (Y)

College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Wenqian Zhou (W)

College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Jinping Guo (J)

College of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Tianbo Jin (T)

School of Medicine, Northwest University, Xi'an 710069, Shaanxi, China; Provincial Key Laboratory of Biotechnology of Shaanxi, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China.

Mingjun Hu (M)

School of Medicine, Northwest University, Xi'an 710069, Shaanxi, China; Key Laboratory of Resource Biology and Biotechnology in Western China, Ministry of Education, School of Life Sciences, Northwest University, Xi'an 710069, Shaanxi, China; Department of Neurosurgery, Xi'an Chest Hospital, Xi'an 710100, Shaanxi, China; Department of Neurosurgery, Xi'an Changan District Hospital, Xi'an 710199, China. Electronic address: slhmj@tom.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH